News

The massive rollout will require a coordinated effort by clinical, business and information technology stakeholders, says Defense Health Agency's William Roberts.

One success story is the Colorado Rural Health Center partnered with Cyberscience Corp. to speed up processes, a move that has saved time and money.

The funding will go toward patient- and provider-facing apps, as well as a ‘store’ where consumers can download them. 

Thomas Carton, director of health services research at REACHnet, also says tablets are changing the way data is managed.

AMIA president touts the need for an informed workforce who can use the data to make EHRs more useful.

LAS VEGAS – WellDoc, a mobile health technology vendor, announced Tuesday at HIMSS16 a collaboration with LifeScan, a blood glucose monitoring business within the Johnson & Johnson Diabetes Care Companies, to deliver a digital health system for patients living with type-2 diabetes. In addition to the collaboration, Johnson & Johnson Innovation/JJDC Inc. participated in WellDoc’s $29.5 million Series B financing. Under the collaboration, WellDoc’s BlueStar product, an FDA-cleared digital therapeutic for adults who live with type-2 diabetes, will be integrated with LifeScan’s OneTouch Verio Flex Bluetooth Smart blood glucose monitoring system and OneTouch Reveal mobile app. The collaboration seeks to leverage LifeScan’s blood glucose monitoring system and mobile app along with the data analytics and patient engagement of WellDoc’s reimbursable mobile prescription therapy to create a real-time, personalized approach to the management of type-2 diabetes. “Together we seek to provide those living with type-2 diabetes a best-in-class diabetes management solution that delivers evidence-based and outcomes-driven support in a consumer-friendly manner,” said Kevin McRaith, CEO of WellDoc. “This is a very significant step forward for our company and has the potential to make a difference in the lives of millions of people living with this chronic disease.” Samsung Ventures, the venture arm of the consumer electronics giant, acted as the lead investor in the initial WellDoc Series B raise with existing investor Merck Global Health Innovation Fund serving as co-lead. Adage Capital Management, Excel Venture Management, Asset Ventures Management, Alexandria Venture Investments, Hudson River Capital Partners LLC and other investors also participated in the financing. WellDoc develops mobile systems to drive behavioral and clinical change in chronic disease with the goal of improving patient self-management and helping physicians overcome gaps in care to improve clinical outcomes and decrease cost. Twitter: @SiwickiHealthIT This story is part of our ongoing coverage of the HIMSS16 conference. Follow our live blog for real-time updates, and visit Destination HIMSS16 for a full rundown of our reporting from the show. For a selection of some of the best social media posts of the show, visit our Trending at #HIMSS16 hub.

Platform is designed to give providers a way to see a more complete view of a patient’s health history.

Technology alone won't make successful implementations, a culture change has to follow suit, according to University of South Carolina's Elizabeth Regan.

Medical records should be able to "to speak and listen in the same language," officials say in HIMSS16 session.

LAS VEGAS – Medisafe, which offers a medication management mobile health app with more than 2.6 million users, launched Tuesday at HIMSS16 Medisafe Providers, a new system that enables physicians, care teams and pharmacists to track their patients’ medication adherence between visits. Using Medisafe Providers, caregivers also can view adherence alongside patient biometric measurements – including blood pressure, blood glucose, weight and others – that Medisafe app users can self-report or bring into the mobile app through various connected devices. Medisafe Providers extends the Medisafe app platform beyond its consumer focus by enabling healthcare professionals to see how their treatment plans are working and to make any needed changes as soon as they identify a problem, helping patients to avoid unnecessary visits and hospitalizations, the company said. [Also: See photos from Day 1 of HIMSS16] The Medisafe app is designed to make it easier for patients to follow the most complicated medication schedules; enable care collaboration between a patient, their family and caregivers; and deliver content and services personalized to specific conditions and situations. “Medisafe Providers reinforces Medisafe’s patient-centric vision by better connecting our users to those guiding their care,” said Omri Shor, CEO and co-founder of Medisafe. “Since the beginning, our users have valued sharing their adherence reports with their doctors and told stories of learning about Medisafe from people on their care teams.” Medisafe will be demonstrating Medisafe Providers at HIMSS16 in the HX360 Pavilion booth A-06. Twitter: @SiwickiHealthIT This story is part of our ongoing coverage of the HIMSS16 conference. Follow our live blog for real-time updates, and visit Destination HIMSS16 for a full rundown of our reporting from the show. For a selection of some of the best social media posts of the show, visit our Trending at #HIMSS16 hub.